Ginkgo Bioworks Holdings - רווח נקי למניה בארבעת הרבעונים האחרונים DNA

Ginkgo Bioworks Holdings (DNA) is transforming its model by prioritizing cloud AI services and software licensing. This rolling annual EPS growth chart illustrates the current trend, where the value has stabilized at 25.40. The company's potential is based on creating a universal biological code for global manufacturing and the synthesis of alternative raw materials, which radically optimizes industrial supply chains.
DNA (Ginkgo Bioworks Holdings): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The EPS TTM YoY trend measures the percentage change in net income per share over a year, reflecting cost management efficiency and business scaling rates. As Ginkgo Bioworks Holdings (DNA) transitions to a royalty model and recurring payments, the current EPS TTM YoY growth rate allows for an assessment of how effectively synthetic biology converts into actual financial results, mitigating the risk of capital freeze when buying at the peak.